CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) — Aurora Backbone Company (“Aurora Backbone” or the “Firm”) (TSXV: ASG) (OTCQB: ASAPF), a producer of revolutionary spinal implants introduced right now that it has accomplished the second full yr of implantation of the world’s first patient-bone-density matched interbody system, the cervical interbody DEXA-C.
Trent Northcutt, CEO and President at Aurora Backbone stated, “It’s a major milestone for Aurora to rejoice the second anniversary of the world’s first surgical implantations of the DEXA-C patient-bone-density matched interbody gadgets. The DEXA-C implants, a line of cervical cages for anterior cervical discectomy with fusion (ACDF) procedures, are the primary of its form on the planet providing an implant primarily based upon a affected person’s bone density. It is usually the primary color-coded implant on {the marketplace} and can assist docs match towards the color-coding of a DEXA rating.”
Dr. Sebastian Koga, Neurosurgeon at Koga Neurosurgery in Covington, Louisiana stated, “After two years and over 200 ranges with the DEXA-C cage, I might by no means return to plain cages or structural allograft. My colleagues who’ve implanted the system, additionally really feel the identical. I’m able to confidently provide multilevel anterior fusions to sufferers who possible couldn’t have benefitted from different present implants due to their bone density. The interface between the woven lattice of the cage and the endplate photos very clearly on x-ray and CT and causes decreased artefact on MRI.”
Aurora introduced in March 2023 that it had obtained Institutional Overview Board (IRB) approval for its new multicenter examine of its DEXA-C Cervical Interbody System, which is indicated for anterior cervical interbody fusion procedures in skeletally mature sufferers with degenerative disc illness (DDD) of the cervical spine with accompanying radicular signs at one or two contiguous ranges from C2-T1.
In June 2023, Aurora introduced that the primary affected person has been enrolled for its multicenter examine of DEXA-CTM Cervical Interbody System. The graduation of the enrollment of sufferers signifies that the corporate has obtained all vital approvals to launch the examine, with preliminary plans to incorporate knowledge from 40 single degree and 40 a number of degree topics.
Dr. Koga continued, “We’re reviewing the primary 100 sufferers in a retrospective scientific examine now, whereas additionally accumulating potential longitudinal knowledge for the DEXA examine. Preliminarily, we’ve seen each in radiographs and surgical exploration that sufferers have incipient bone fusion by 90 days after surgical procedure. This expertise is now ripe for duplication in tougher areas of the spine. I proceed to imagine that that progress is contingent on new biomaterials, and that such personalised implants will revolutionize spine surgical procedure.”
In February 2024, Aurora introduced the issuance of its second United States Patent No: 11,850,162 entitled “Physique Density Scan End result-Matched Orthopedic Implants and Strategies of Use” for The World’s First DEXA Know-how™ Affected person-Matched Implant Know-how.
Aurora is targeted on the discharge of different gadgets using the patented DEXA Know-how. Northcutt said, “These patents will permit us to create DEXA implants to be used wherever within the human physique the place bone fixation is required offering sufferers with beforehand non-existing new remedy prospects.”
About Aurora Backbone
Aurora Backbone is targeted on bringing new options to the spinal implant market by means of a collection of revolutionary, minimally invasive, regenerative spinal implant applied sciences. Extra info could be accessed at www.aurora-spine.com or www.aurorapaincare.com.
Neither TSX Enterprise Alternate nor its Regulation Providers Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Alternate) accepts duty for the adequacy or accuracy of this launch.
Ahead-Trying Statements
This information launch comprises forward-looking info that includes substantial recognized and unknown dangers and uncertainties, most of that are past the management of Aurora Backbone, together with, with out limitation, these listed beneath “Threat Elements” and “Cautionary Assertion Relating to Ahead-Trying Data” in Aurora Backbone’s closing prospectus (collectively, “forward-looking info”). Ahead-looking info on this information launch contains info regarding the proposed use and success of the corporate’s merchandise in surgical procedures. Aurora Backbone cautions buyers of Aurora Backbone’s securities about necessary components that would trigger Aurora Backbone’s precise outcomes to vary materially from these projected in any forward-looking statements included on this information launch. Any statements that specific, or contain discussions as to, expectations, beliefs, plans, aims, assumptions or future occasions or efficiency are usually not historic information and could also be forward-looking and should contain estimates, assumptions and uncertainties which might trigger precise outcomes or outcomes to vary unilaterally from these expressed in such forward-looking statements. No assurance could be provided that the expectations set out herein will show to be right and, accordingly, potential buyers shouldn’t place undue reliance on these forward-looking statements. These statements communicate solely as of the date of this press launch and Aurora Backbone doesn’t assume any obligation to replace or revise them to mirror new occasions or circumstances.
Contact:
Aurora Backbone Company
Trent Northcutt
President and Chief Govt Officer
(760) 424-2004
Chad Clouse
Chief Monetary Officer
(760) 424-2004
www.aurora-spine.com
Discussion about this post